COVID-19 vaccine makers should license technology to overcome 'grotesque' inequity: WHO

Health News
FILE PHOTO: A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo

GENEVA (Reuters) – More producers of COVID-19 vaccines should follow the example of AstraZeneca and license their technology to other manufacturers, the head of the World Health Organization (WHO) said on Monday, as he described vaccine inequity as “grotesque”.

WHO Director-General Tedros Adhanom Ghebreyesus noted that the drugmaker said earlier that interim data from trials found the vaccine, developed in conjunction with Oxford University, was 79% effective in preventing symptomatic COVID-19 and, crucially, posed no increased risk of blood clots.

“This data is further evidence that the AstraZeneca vaccine is safe and effective,” Tedros told a news conference.

Source: Read Full Article

Related posts:

J&J applies for COVID-19 vaccine emergency authorisation from South Africa Novavax completes enrolling 30,000 people in U.S. trial of COVID-19 vaccine CureVac gets vaccine production support from Novartis Denmark suspends AstraZeneca COVID vaccine after blood clot reports Spain prepares to extends use of AstraZeneca vaccine to 18-65 year olds: media
, , , , , , , , ,